Piasky 340 mg/ 2 ml, Injektions-/Infusionslösung
7680693400016
CH-69340
L04AJ07
07.15.0.
Reimbursement limitations:
ONCASPAR
Oncaspar est indiqué en association à d’autres agents antinéoplasiques pour le traitement de la leucémie …
1 / 3
google
Details
- GTIN
- 7680693400016
- Pharmacode
- -
- Product number
- 6934001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- crovalimabum 340 mg, histidinum, acidum asparticum q.s. ad pH, arginini hydrochloridum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Articles (1)
Piasky 340 mg/ 2 ml, Injektions-/Infusionslösung
Injektions-/Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
crovalimabum
|
340.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
acidum asparticum
|
- | Substance | HNIDK |
|
arginini hydrochloridum
|
- | Substance | HNIDK |
|
poloxamerum 188
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 69340
- Drug name
- Piasky, Injektions-/Infusionslösung
- Galenic form
- LSIN
- ATC Code
- L04AJ07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/02/2025
- Authorization expiration date
- 12/02/2030
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PIASKY sol inj perf 340 mg/2 ml flac 2 ml
- Description (DE)
- PIASKY Inj Inf Lös 340 mg/2 ml Durchstf 2 ml
- Market launch
- 13/02/2025
- Market withdrawal
- 13/02/2025
- Narcotic (BTM)
- No